Deletions of chromosomes 9 and 8p in histologically normal urothelium of patients with bladder cancer.
about
Gene expression profile of cervical tissue compared to exfoliated cells: impact on biomarker discoveryAnalysis of the interaction of extracellular matrix and phenotype of bladder cancer cells.Mismatch repair proteins hMLH1 and hMSH2 are differently expressed in the three main subtypes of sporadic renal cell carcinomaIdentification of novel drugs to target dormant micrometastasesMolecular markers in transitional cell carcinoma of the bladder: New insights into mechanisms and prognosisPredicting tumor outcomes in urothelial bladder carcinoma: turning pathways into clinical biomarkers of prognosis.Frequency of activating mutations in FGFR2 exon 7 in bladder tumors from patients with early-onset and regular-onset disease.Urothelial tumorigenesis: a tale of divergent pathways.Aneuploidy in bladder cancers: the utility of fluorescent in situ hybridization in clinical practice.Are keratoacanthomas variants of squamous cell carcinomas? A comparison of chromosomal aberrations by comparative genomic hybridization.Molecular determinants of tumor recurrence in the urinary bladder.Immunohistochemical and molecular characterizations in urothelial carcinoma of bladder in patients less than 45 years.The route to personalized medicine in bladder cancer: where do we stand?TERT Core Promotor Mutations in Early-Onset Bladder Cancer.The human urothelium consists of multiple clonal units, each maintained by a stem cell.Lack of evidence for frequent MED12 p.L1224F mutation in prostate tumours from Caucasian patients.A methylation assay for the detection of non-muscle-invasive bladder cancer (NMIBC) recurrences in voided urine.
P2860
Q24814177-1902F06C-143D-480A-A146-55324DC1FCF5Q25255773-500720B0-16F2-43D9-AFDC-9D69CC97D71AQ28260995-16FEA37B-FCDC-4DD1-98D7-92263FEB29E6Q28394296-68B3527E-F1F0-4029-9927-50FEDB8CAB2CQ30439612-7964BF24-25E8-42A1-8D68-C76B5154286EQ30446429-47E80C0D-E544-4F0C-80CA-CD5DC7CA4CFEQ33583057-2823127B-750A-4E68-BC27-1FEC54CD538EQ36234720-51D33C1B-B584-41B4-BF49-8FF8B809D26CQ36532210-DECB5A97-C3A1-4891-A726-65CD47CB3D2CQ36711040-77F0CD3C-C101-4815-9219-886BD9F2534CQ37575626-1DAAD080-4E0E-45F2-8A13-848352C0F615Q37675922-AD92B4C0-1F60-4627-93BE-1356EFC9E3A6Q38337192-E3199525-7793-49CB-BB5B-F0E02E720C18Q39676067-86064074-6310-4E6E-BF36-1CE12D06319AQ42491329-276E4A23-B12B-4953-9806-DB7CE4C00114Q51005724-5B0C5EE0-49D6-4310-88B0-987DCA213EA8Q54357139-67798A72-D405-49DA-9F6F-5AC085D2FCB6
P2860
Deletions of chromosomes 9 and 8p in histologically normal urothelium of patients with bladder cancer.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Deletions of chromosomes 9 and ...... patients with bladder cancer.
@ast
Deletions of chromosomes 9 and ...... patients with bladder cancer.
@en
type
label
Deletions of chromosomes 9 and ...... patients with bladder cancer.
@ast
Deletions of chromosomes 9 and ...... patients with bladder cancer.
@en
prefLabel
Deletions of chromosomes 9 and ...... patients with bladder cancer.
@ast
Deletions of chromosomes 9 and ...... patients with bladder cancer.
@en
P2093
P1433
P1476
Deletions of chromosomes 9 and ...... patients with bladder cancer.
@en
P2093
Arndt Hartmann
Christine Hammerschmied
Ellen C Obermann
Maximilian Burger
Robert Stoehr
Sabrina Zietz
Stefan Denzinger
Thomas Filbeck
Wolf F Wieland
P356
10.1016/J.EURURO.2004.07.012
P407
P577
2005-01-01T00:00:00Z